Cargando…

Sex influences clinical phenotype in frontotemporal dementia

INTRODUCTION: Frontotemporal dementia (FTD) encompasses a wide spectrum of genetic, clinical, and histological findings. Sex is emerging as a potential biological variable influencing FTD heterogeneity; however, only a few studies explored this issue with nonconclusive results. OBJECTIVE: To estimat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pengo, Marta, Alberici, Antonella, Libri, Ilenia, Benussi, Alberto, Gadola, Yasmine, Ashton, Nicholas J., Zetterberg, Henrik, Blennow, Kaj, Borroni, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385756/ https://www.ncbi.nlm.nih.gov/pubmed/35672480 http://dx.doi.org/10.1007/s10072-022-06185-7

Ejemplares similares

Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single‐center cohort study
por: Benussi, Alberto, et al.
Publicado: (2022)

Prodromal frontotemporal dementia: clinical features and predictors of progression
por: Benussi, Alberto, et al.
Publicado: (2021)

Modifiable potential risk factors in familial and sporadic frontotemporal dementia
por: Soppela, Helmi, et al.
Publicado: (2022)

Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration
por: Benussi, Alberto, et al.
Publicado: (2022)

Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia
por: Benussi, Alberto, et al.
Publicado: (2015)

Toward a Glutamate Hypothesis of Frontotemporal Dementia
por: Benussi, Alberto, et al.
Publicado: (2019)

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
por: Meda, Francisco, et al.
Publicado: (2023)

Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin
por: Borroni, Barbara, et al.
Publicado: (2018)

Neuroanatomical correlates of screening for aphasia in NeuroDegeneration (SAND) battery in non-fluent/agrammatic variant of primary progressive aphasia
por: Premi, Enrico, et al.
Publicado: (2022)

Dissecting the Many Faces of Frontotemporal Dementia: An Imaging Perspective
por: Pengo, Marta, et al.
Publicado: (2022)

Transcranial stimulation in frontotemporal dementia: A randomized, double‐blind, sham‐controlled trial
por: Benussi, Alberto, et al.
Publicado: (2020)

Unravelling neurotransmitters impairment in primary progressive aphasias
por: Premi, Enrico, et al.
Publicado: (2023)

Dyslexia susceptibility genes influence brain atrophy in frontotemporal dementia
por: Paternicó, Donata, et al.
Publicado: (2015)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
por: Ashton, Nicholas J., et al.
Publicado: (2021)

Cognitive Reserve in Granulin-Related Frontotemporal Dementia: from Preclinical to Clinical Stages
por: Premi, Enrico, et al.
Publicado: (2013)

Recent advances in understanding frontotemporal degeneration
por: Borroni, Barbara, et al.
Publicado: (2019)

Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
por: Spotorno, Nicola, et al.
Publicado: (2020)

Synergistic Association between Plasma Aβ(1–42) and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
por: Chiu, Ming-Jang, et al.
Publicado: (2021)

Frontotemporal dementia and language networks: cortical thickness reduction is driven by dyslexia susceptibility genes
por: Paternicó, Donata, et al.
Publicado: (2016)

CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
por: Clarke, Mica T. M., et al.
Publicado: (2019)

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
por: Ashton, Nicholas J., et al.
Publicado: (2019)

Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre‐analytical conditions
por: Simrén, Joel, et al.
Publicado: (2021)

Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype
por: Katisko, Kasper, et al.
Publicado: (2022)

Endo‐lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation
por: Toft, Anders, et al.
Publicado: (2023)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
por: Karikari, Thomas K., et al.
Publicado: (2022)

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
por: Rohrer, Jonathan D., et al.
Publicado: (2016)

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
por: Foiani, Martha S, et al.
Publicado: (2019)

Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
por: Falgàs, Neus, et al.
Publicado: (2020)

Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target
por: Borroni, B., et al.
Publicado: (2017)

Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
por: Montoliu-Gaya, Laia, et al.
Publicado: (2021)

Plasma tau is increased in frontotemporal dementia
por: Foiani, Martha S, et al.
Publicado: (2018)

New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia
por: del Campo, Marta, et al.
Publicado: (2022)

Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia
por: Benussi, Alberto, et al.
Publicado: (2021)

Neuropathological background of phenotypical variability in frontotemporal dementia
por: Josephs, Keith A., et al.
Publicado: (2011)

Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
por: Giunta, Marcello, et al.
Publicado: (2021)

CSF placental growth factor – a novel candidate biomarker of frontotemporal dementia
por: Hansson, Oskar, et al.
Publicado: (2019)

Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target
por: Borroni, B., et al.
Publicado: (2018)

Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2022)

Validation of a prefractionation method followed by two-dimensional electrophoresis – Applied to cerebrospinal fluid proteins from frontotemporal dementia patients
por: Hansson, Sara Folkesson, et al.
Publicado: (2004)

Latent profile analysis in frontotemporal lobar degeneration and related disorders: clinical presentation and SPECT functional correlates
por: Borroni, Barbara, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ma8g3mtkbuq7ptb2lakbksoahj